Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-11

Clinical Trial Update: Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease [Phase 1]

View source ↗

Summary

This clinical trial update reports on the safety assessment of allogeneic human umbilical cord mesenchymal stem cells for treating perianal fistulas in Crohn's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic human umbilical cord mesenchymal stem cells (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: CryoCord Sdn Bhd | Conditions: Perianal Fistula Due to Crohn's Disease, Fistula in Ano | Phase 1 | Status: RECRUITING